Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial)

BACKGROUND: Eighty percent of children with steroid-sensitive nephrotic syndrome (SSNS) relapse within 2 years and 40–50% patients show frequently-relapsing nephrotic syndrome (FRNS). Patients showing a relapse within 6 months after initial remission are at high risk of FRNS. Since frequent predniso...

Descripción completa

Detalles Bibliográficos
Autores principales: Hama, Taketsugu, Nakanishi, Koichi, Ishikura, Kenji, Ito, Shuichi, Nakamura, Hidefumi, Sako, Mayumi, Saito-Oba, Mari, Nozu, Kandai, Shima, Yuko, Iijima, Kazumoto, Yoshikawa, Norishige
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131840/
https://www.ncbi.nlm.nih.gov/pubmed/30200895
http://dx.doi.org/10.1186/s12882-018-1033-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131840/
https://www.ncbi.nlm.nih.gov/pubmed/30200895
http://dx.doi.org/10.1186/s12882-018-1033-z

Ejemplares similares